2.4. Experimental Design
This study was a multicenter, randomized, double-blind, placebo-controlled clinical trial of 93 participants who were randomized 1:1 to receive either an FP-MD or placebo soft gel once daily by mouth for 12 weeks. The random allocation sequence was generated by a randomization program of the SAS